<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">30345135</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2090-6803</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>2018</Volume>
            <PubDate>
              <Year>2018</Year>
            </PubDate>
          </JournalIssue>
          <Title>Case reports in pediatrics</Title>
          <ISOAbbreviation>Case Rep Pediatr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neuropsychiatric Disorder Associated with Group G <i>Streptococcus</i> Infection.</ArticleTitle>
        <Pagination>
          <StartPage>6047318</StartPage>
          <MedlinePgn>6047318</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">6047318</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/6047318</ELocationID>
        <Abstract>
          <AbstractText>Immune-mediated central nervous system manifestations of group A <i>β</i>-hemolytic <i>Streptococcus</i> (GABHS) infection include Sydenham's chorea, pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS)-which includes tic and obsessive compulsive disorders-and a variety of neurobehavioral disorders. We report a case of <i>Streptococcus dysgalactiae</i> subspecies <i>equisimilis</i> (group G <i>Streptococcus</i>) (GGS) infection associated with involuntary movements, complex tics, and emotional lability in an 11-year-old Japanese girl. Serum IgM and IgG antibodies to lysoganglioside were positive, and she responded rapidly to intravenous immunoglobulin treatment. Neuropsychiatric disorder associated with GGS infection was ultimately diagnosed. The present findings suggest that neuropsychiatric disorders can result from GGS infection and that the pathogenic mechanism is similar to that of GABHS infection. Future large-scale studies should examine the relation between GGS infection and onset of neuropsychiatric disorder.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Okumura</LastName>
            <ForeName>Rie</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0001-7872-6563</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata City General Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata Prefecture Hamagumi Medical Rehabilitation Center for Disabled Children, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamazaki</LastName>
            <ForeName>Sawako</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata City General Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata Minami Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ohashi</LastName>
            <ForeName>Tsukasa</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child Neurology, Nishi-Niigata Chuo National Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Magara</LastName>
            <ForeName>Shinichi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child Neurology, Nishi-Niigata Chuo National Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tohyama</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child Neurology, Nishi-Niigata Chuo National Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sakuma</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0001-8736-9027</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hayashi</LastName>
            <ForeName>Masaharu</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-5545-0741</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Nursing, College of Nursing and Nutrition, Shukutoku University, Chiba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saitoh</LastName>
            <ForeName>Akihiko</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata University, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Case Rep Pediatr</MedlineTA>
        <NlmUniqueID>101581030</NlmUniqueID>
      </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30345135</ArticleId>
        <ArticleId IdType="pmc">PMC6174767</ArticleId>
        <ArticleId IdType="doi">10.1155/2018/6047318</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hachiya Y., Miyata R., Tanuma N., et al.  Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection. Brain and Development. 2013;35(7):670–674. doi: 10.1016/j.braindev.2012.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.braindev.2012.10.003</ArticleId>
            <ArticleId IdType="pubmed">23142103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bramhachari P. V., Kaul S. Y., McMillan D. J., Shaila M. S., Karmarkar M. G., Sriprakash K. S. Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children. Journal of Medical Microbiology. 2010;59(2):220–223. doi: 10.1099/jmm.0.015644-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.015644-0</ArticleId>
            <ArticleId IdType="pubmed">19833781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDonald M., Towers R. J., Andrews R. M., Carapetis J. R., Currie B. J. Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in tropical communities, Northern Australia. Emerging Infectious Diseases. 2007;13(11):1694–1700. doi: 10.3201/eid1311.061258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1311.061258</ArticleId>
            <ArticleId IdType="pmc">PMC3375807</ArticleId>
            <ArticleId IdType="pubmed">18217553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haidan A., Talay S. R., Rohde M., Sriprakash K. S., Currie B. J., Chhatwal G. S. Pharyngeal carriage of group C and G streptococci and acute rheumatic fever in an aboriginal population. The Lancet. 2000;356(9236):1167–1169. doi: 10.1016/s0140-6736(00)02765-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0140-6736(00)02765-3</ArticleId>
            <ArticleId IdType="pubmed">11030302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirvan C. A., Swedo S. E., Snider L. A., Cunningham M. W. Antibody-mediated neuronal cell signaling in behavior and movement disorders. Journal of Neuroimmunology. 2006;179(1-2):173–179. doi: 10.1016/j.jneuroim.2006.06.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2006.06.017</ArticleId>
            <ArticleId IdType="pubmed">16875742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams G. S. Group C and G streptococci infections: emerging challenges. Clinical Laboratory Science. 2003;16(4):209–213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14626438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurlan R., Johnson D., Kaplan E. L. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics. 2008;121(6):1188–1197. doi: 10.1542/peds.2007-2657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2007-2657</ArticleId>
            <ArticleId IdType="pubmed">18519489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham M. W. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. International Reviews of Immunology. 2014;33(4):314–329. doi: 10.3109/08830185.2014.917411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08830185.2014.917411</ArticleId>
            <ArticleId IdType="pmc">PMC4669348</ArticleId>
            <ArticleId IdType="pubmed">24892819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dale R. C., Merheb V., Pillai S., et al.  Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135(11):3453–3468. doi: 10.1093/brain/aws256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/aws256</ArticleId>
            <ArticleId IdType="pubmed">23065479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitaliti G., Tabatabaie O., Matin N., et al.  The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. Human Vaccines &amp; Immunotherapeutics. 2015;11(12):2749–2763. doi: 10.1080/21645515.2015.1061161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21645515.2015.1061161</ArticleId>
            <ArticleId IdType="pmc">PMC5391617</ArticleId>
            <ArticleId IdType="pubmed">26266339</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">30345135</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2090-6803</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>2018</Volume>
            <PubDate>
              <Year>2018</Year>
            </PubDate>
          </JournalIssue>
          <Title>Case reports in pediatrics</Title>
          <ISOAbbreviation>Case Rep Pediatr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neuropsychiatric Disorder Associated with Group G <i>Streptococcus</i> Infection.</ArticleTitle>
        <Pagination>
          <StartPage>6047318</StartPage>
          <MedlinePgn>6047318</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">6047318</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/6047318</ELocationID>
        <Abstract>
          <AbstractText>Immune-mediated central nervous system manifestations of group A <i>β</i>-hemolytic <i>Streptococcus</i> (GABHS) infection include Sydenham's chorea, pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS)-which includes tic and obsessive compulsive disorders-and a variety of neurobehavioral disorders. We report a case of <i>Streptococcus dysgalactiae</i> subspecies <i>equisimilis</i> (group G <i>Streptococcus</i>) (GGS) infection associated with involuntary movements, complex tics, and emotional lability in an 11-year-old Japanese girl. Serum IgM and IgG antibodies to lysoganglioside were positive, and she responded rapidly to intravenous immunoglobulin treatment. Neuropsychiatric disorder associated with GGS infection was ultimately diagnosed. The present findings suggest that neuropsychiatric disorders can result from GGS infection and that the pathogenic mechanism is similar to that of GABHS infection. Future large-scale studies should examine the relation between GGS infection and onset of neuropsychiatric disorder.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Okumura</LastName>
            <ForeName>Rie</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0001-7872-6563</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata City General Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata Prefecture Hamagumi Medical Rehabilitation Center for Disabled Children, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamazaki</LastName>
            <ForeName>Sawako</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata City General Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata Minami Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ohashi</LastName>
            <ForeName>Tsukasa</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child Neurology, Nishi-Niigata Chuo National Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Magara</LastName>
            <ForeName>Shinichi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child Neurology, Nishi-Niigata Chuo National Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tohyama</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child Neurology, Nishi-Niigata Chuo National Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sakuma</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0001-8736-9027</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hayashi</LastName>
            <ForeName>Masaharu</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-5545-0741</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Nursing, College of Nursing and Nutrition, Shukutoku University, Chiba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saitoh</LastName>
            <ForeName>Akihiko</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Niigata University, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Case Rep Pediatr</MedlineTA>
        <NlmUniqueID>101581030</NlmUniqueID>
      </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30345135</ArticleId>
        <ArticleId IdType="pmc">PMC6174767</ArticleId>
        <ArticleId IdType="doi">10.1155/2018/6047318</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hachiya Y., Miyata R., Tanuma N., et al.  Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection. Brain and Development. 2013;35(7):670–674. doi: 10.1016/j.braindev.2012.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.braindev.2012.10.003</ArticleId>
            <ArticleId IdType="pubmed">23142103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bramhachari P. V., Kaul S. Y., McMillan D. J., Shaila M. S., Karmarkar M. G., Sriprakash K. S. Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children. Journal of Medical Microbiology. 2010;59(2):220–223. doi: 10.1099/jmm.0.015644-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.015644-0</ArticleId>
            <ArticleId IdType="pubmed">19833781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDonald M., Towers R. J., Andrews R. M., Carapetis J. R., Currie B. J. Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in tropical communities, Northern Australia. Emerging Infectious Diseases. 2007;13(11):1694–1700. doi: 10.3201/eid1311.061258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1311.061258</ArticleId>
            <ArticleId IdType="pmc">PMC3375807</ArticleId>
            <ArticleId IdType="pubmed">18217553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haidan A., Talay S. R., Rohde M., Sriprakash K. S., Currie B. J., Chhatwal G. S. Pharyngeal carriage of group C and G streptococci and acute rheumatic fever in an aboriginal population. The Lancet. 2000;356(9236):1167–1169. doi: 10.1016/s0140-6736(00)02765-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0140-6736(00)02765-3</ArticleId>
            <ArticleId IdType="pubmed">11030302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirvan C. A., Swedo S. E., Snider L. A., Cunningham M. W. Antibody-mediated neuronal cell signaling in behavior and movement disorders. Journal of Neuroimmunology. 2006;179(1-2):173–179. doi: 10.1016/j.jneuroim.2006.06.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2006.06.017</ArticleId>
            <ArticleId IdType="pubmed">16875742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams G. S. Group C and G streptococci infections: emerging challenges. Clinical Laboratory Science. 2003;16(4):209–213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14626438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurlan R., Johnson D., Kaplan E. L. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics. 2008;121(6):1188–1197. doi: 10.1542/peds.2007-2657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2007-2657</ArticleId>
            <ArticleId IdType="pubmed">18519489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham M. W. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. International Reviews of Immunology. 2014;33(4):314–329. doi: 10.3109/08830185.2014.917411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08830185.2014.917411</ArticleId>
            <ArticleId IdType="pmc">PMC4669348</ArticleId>
            <ArticleId IdType="pubmed">24892819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dale R. C., Merheb V., Pillai S., et al.  Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135(11):3453–3468. doi: 10.1093/brain/aws256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/aws256</ArticleId>
            <ArticleId IdType="pubmed">23065479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitaliti G., Tabatabaie O., Matin N., et al.  The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. Human Vaccines &amp; Immunotherapeutics. 2015;11(12):2749–2763. doi: 10.1080/21645515.2015.1061161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21645515.2015.1061161</ArticleId>
            <ArticleId IdType="pmc">PMC5391617</ArticleId>
            <ArticleId IdType="pubmed">26266339</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
